We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.1B
AUM Growth
-$1.32B
Cap. Flow
-$1.84B
Cap. Flow %
-12.19%
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$66.7M
2
MSCI icon
MSCI
MSCI
+$54.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
4
RMD icon
ResMed
RMD
+$44.7M
5
PPG icon
PPG Industries
PPG
+$43.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$74M
2
LHX icon
L3Harris
LHX
+$69.6M
3
HON icon
Honeywell
HON
+$64.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$60.2M
5
WFC icon
Wells Fargo
WFC
+$59.2M

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Consumer Discretionary 8.49%
3 Financials 8.33%
4 Industrials 8.18%
5 Healthcare 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFYA icon
3426
Afya
AFYA
$1.23B
-62,816
Closed -$701K
AGNC icon
3427
AGNC Investment
AGNC
$12.8B
-28,779
Closed -$290K
AGS
3428
DELISTED
PlayAGS
AGS
-125,420
Closed -$897K
AHCO icon
3429
AdaptHealth
AHCO
$696M
-16,378
Closed -$204K
AHRT
3430
AH Realty Trust
AHRT
$503M
-20,907
Closed -$247K
AIG icon
3431
American International
AIG
$40.7B
-38,566
Closed -$2.07M
AKRO
3432
DELISTED
Akero Therapeutics
AKRO
-19,778
Closed -$757K
ALB icon
3433
Albemarle
ALB
$15.5B
-4,699
Closed -$961K
ALDX icon
3434
Aldeyra Therapeutics
ALDX
$91.1M
-5,757
Closed -$57.2K
ALEC icon
3435
Alector
ALEC
$189M
-43,010
Closed -$266K
ALGT icon
3436
CALL
Allegiant Air
ALGT
$2.41B
-5,800
Closed -$533K
ALGT icon
3437
PUT
Allegiant Air
ALGT
$2.41B
-11,200
Closed -$1.03M
ALGS icon
3438
Aligos Therapeutics
ALGS
$47.8M
-532
Closed -$11.6K
ALK icon
3439
Alaska Air
ALK
$5.27B
-8,276
Closed -$376K
ALKT icon
3440
Alkami Technology
ALKT
$2.1B
-6,002
Closed -$76K
ALL icon
3441
Allstate
ALL
$68.2B
-284,518
Closed -$32.3M
ALLK
3442
DELISTED
Allakos
ALLK
-119,164
Closed -$530K
ALTI icon
3443
AlTi Global
ALTI
$476M
-5,023
Closed -$63K
ALXO icon
3444
ALX Oncology
ALXO
$285M
-33,869
Closed -$153K
AM icon
3445
Antero Midstream
AM
$10.4B
-45,144
Closed -$474K
AMAL icon
3446
Amalgamated Financial
AMAL
$1.48B
-26,578
Closed -$470K
AMBA icon
3447
Ambarella
AMBA
$3.6B
-92,296
Closed -$6.75M
OSG
3448
Octave Specialty Group
OSG
$210M
-63,247
Closed -$979K
AMCR icon
3449
Amcor
AMCR
$21.8B
-25,173
Closed -$1.43M
AMD icon
3450
Advanced Micro Devices
AMD
$767B
-2,400
Closed -$250K

Similar funds

Cubist Systematic Strategies's Q2 2023 Portfolio in Review

As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.

  • Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
  • Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
  • Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
  • Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
  • Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
  • Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.